...
首页> 外文期刊>Drug delivery and translational research >Polycaprolactone scaffold as targeted drug delivery system and cell attachment scaffold for postsurgical care of limb salvage
【24h】

Polycaprolactone scaffold as targeted drug delivery system and cell attachment scaffold for postsurgical care of limb salvage

机译:聚己内酯支架作为靶向药物输送系统和细胞附着支架,用于肢体抢救的术后护理

获取原文
获取原文并翻译 | 示例

摘要

In this paper, a dual-function drug-laden polycaprolactone scaffold, which can serve as both targeted drug delivery system and attachment platform for tissue regeneration for the postsurgical care of limb salvage procedure, was developed with a simple and solvent-free molding technique. Scaffolds of varying surface architecture were created using poly(ethylene glycol) diacrylate microneedle arrays. A model drug, rhodamine B, was incorporated homogenously into the scaffold. In vitro drug release studies showed that rhodamine B was released in a slow and sustained manner for 112 days. Its release rate was affected by drug loading and scaffold surface architecture. Release of rhodamine B from the scaffolds followed the Higuchi diffusion model. Other drugs, namely, doxorubicin and lidocaine hydrochloride, were also effectively loaded into and released from the scaffolds. Cell attachment study demonstrated potential for the scaffolds to provide attachment platforms for tissue regeneration.
机译:在本文中,采用简单且无溶剂的成型技术开发了一种双功能载药聚己内酯支架,该支架既可以用作靶向药物递送系统,又可以作为组织再生的附着平台,用于肢体抢救手术的术后护理。使用聚(乙二醇)二丙烯酸酯微针阵列创建了具有不同表面结构的支架。将模型药物罗丹明B同质掺入支架中。体外药物释放研究表明,若丹明B以缓慢持续的方式释放了112天。其释放速率受药物载量和支架表面结构的影响。罗丹明B从支架上的释放遵循Higuchi扩散模型。其他药物,即阿霉素和盐酸利多卡因,也有效地加载到支架中并从支架中释放出来。细胞附着研究证明了支架为组织再生提供附着平台的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号